Fish and apoptosis: Studies in disease and pharmaceutical design

Current Pharmaceutical Design

Volumn 14, Issue 2, 2008, Pages 170-183

  Silva, M T ^a   do Vale, A ^a   dos Santos, N M S ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

Cancer; Drug design; Fish apoptosis; Infection; Neurodegenerative diseases

Indexed keywords

AMYLOID BETA PROTEIN; ANTINEOPLASTIC AGENT; ANTIOXIDANT; AZATHIOPRINE; CASPASE 3 INHIBITOR; CELLULAR APOPTOSIS SUSCEPTIBILITY PROTEIN; CYCLIN DEPENDENT KINASE 5; MICRORNA; MYC PROTEIN; NEUROPROTECTIVE AGENT; PRESINILIN ENHANCER 2; PROTEIN BCL 2; PROTEIN DERIVATIVE; PROTEIN P53; PROTEINASE INHIBITOR; SOMATOMEDIN BINDING PROTEIN 3; TAU PROTEIN; UNCLASSIFIED DRUG;

AEROMONAS HYDROPHILA; ANOIKIS; APOPTOSIS; BACTERIAL INFECTION; CELL DEATH; DEGENERATIVE DISEASE; DRUG DESIGN; DRUG SCREENING; EXPERIMENTAL MODEL; FISH DISEASE; FISH GENETICS; GENOME; HIGH THROUGHPUT SCREENING; HOST PATHOGEN INTERACTION; IMMUNE SYSTEM; IMMUNOTOXICITY; NEOPLASM; NERVE CELL NECROSIS; NONHUMAN; PHAGOCYTOSIS; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PUFFER FISH; REVIEW; SEQUENCE ANALYSIS; STREPTOCOCCUS INIAE; TOXICITY TESTING; VERTEBRATE; VIRUS INFECTION; ZEBRA FISH; ANIMAL; DISEASE MODEL; DRUG EFFECT; FISH; GROWTH, DEVELOPMENT AND AGING; INFECTION; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ANOIKIS; APOPTOSIS; DISEASE MODELS, ANIMAL; DRUG DESIGN; FISHES; INFECTION; NEOPLASMS; NEURODEGENERATIVE DISEASES;

EID: 38949102730     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161208783378734     Document Type: Review

References (221)

1. FAO-2006. The state of world fisheries and aquaculture. ftp://ftpfaoorg/ docrep/fao/009/a0699e/a0699epdf, May 2007.
2. http://oslovet.veths.no/gardermoen.pdf, May 2007.
3. Bradbury J. Small fish, big science. PLoS Biol 2004; 2(5): E148.
4. Johansen R, Needham JR, Colquhoun DJ, Poppe TT, Smith AJ. Guidelines for health and welfare monitoring of fish used in research. Lab Anim 2006; 40(4): 323-40.
5. Powers DA. Fish as modal systems. Science 1989; 246(4928): 352-8.
6. Hariharan IK, Haber DA. Yeast, flies, worms, and fish in the study of human disease. N Engl J Med 2003; 348(24): 2457-63.
7. Friedmann HC. From "butyribacterium" to "E. coli": An essay on unity in biochemistry. Perspect Biol Med 2004; 47(1): 47-66.
8. Brunet FG, Crollius HR, Paris M, Aury JM, Gibert P, Jaillon O, et al. Gene loss and evolutionary rates following whole-genome duplication in teleost fishes. Mol Biol Evol 2006; 23(9): 1808-16.
9. Hill AJ, Teraoka H, Heideman W, Peterson RE. Zebrafish as a model vertebrate for investigating chemical toxicity. Toxicol Sci 2005; 86(1): 6-19.
10. Chen TT, Vrolijk NH, Lu JK, Lin CM, Reimschuessel R, Dunham RA. Transgenic fish and its application in basic and-applied research. Biotechnol Annu Rev 1996; 2: 205-36.
11. Winn RN. Trangenic fish as models in environmental toxicology. ILAR J 2001; 42(4): 322-9.
12. Dooley K, Zon LI. Zebrafish: A model system for the study of human disease. Curr Opin Genet Dev 2000; 10(3): 252-6.
13. Chistiakov DA, Hellemans B, Volckaert FA. Review on the immunology of European sea bass Dicentrarchus labrax. Vet Immunol Immunopathol 2007; 117(1-2): 1-16.
14. Ishikawa Y. Medakafish as a model system for vertebrate developmental genetics. Bioessays 2000; 22(5): 487-95.
15. Wittbrodt J, Shima A, Schartl M. Medaka - a model organism from the far East. Nat Rev Genet 2062; 3(1): 53-64.
16. Goldsmith P. Zebrafith as a pharmacological tool: The how, why and when. Curr Opin Pharmacol 2004; 4(5): 504-12.
17. Inohara N, Nunez G. Genes with homology to mammalian apoptosis regulators identified in zebrafish. Cell Death Differ 2000; 7(5): 509-10.
18. Langenau DM, Zen LI. The zebrafish: A new model of T-cell and thymic development. Nat Rev Immunol 2005; 5(4): 307-17.
19. Parng C, Seng WL, Semino C, McGrath P. Zebrafish: A preclinical model for drug screening. Assay Drug Dev Technol 2002; 1(1 Pt 1): 41-8.
20. Patton EE, Zen LI. The art and design of genetic screens: Zebrafish. Nat Rev Genet 2001; 2(12): 956-66.
21. Pyati UJ, Look AT, Hammerschmidt M. Zebrafish as a powerful vertebrate model system for in vivo studies of cell death. Semin Cancer Biol 2007; 17(2): 154-65.
22. Berghmans S, Jette C, Langenau D, Hsu K, Stewart R, Look T, et al. Making waves in cancer research: New models in the zebrafish. Biotechniques 2005; 39(2): 227-37.
23. Saikumar P, Dong Z, Mikhailov V, Denton M, Weinberg JM, Venkatachalam MA. Apoptosis: Definition, mechanisms, and relevance to disease. Am J Med 1999; 107(5): 489-506.
24. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267(5203): 1456-62.
25. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988; 335(6189): 440-2.
26. Adams JM, Cory S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 2007; 26(9): 1324-37.
27. Fabregat I, Roncero C, Fernandez M. Survival and apoptosis: A dysregulated balance in liver cancer. Liver Int 2007; 27(2): 155-62.
28. Mehlen P, Puisieux A. Metastasis: A question of life or death. Nat Rev Cancer 2006; 6(6): 449-58.
29. Russo A, Terrasi M, Agnese V, Santini D, Bazan V. Apoptosis: A relevant tool for anticancer therapy. Ann Oncol 2006; 17(Suppl 7). vii115-vii23.
30. Meng XW, Lee SH, Kaufmann SH. Apoptosis in the treatment of cancer: A promise kept? Curr Opin Cell Biol 2006; 18(6): 668-76.
31. Amatruda JF, Shepard JL, Stern HM, Zon LI. Zebrafish as a cancer model system. Cancer Cell 2002; 1(3): 229-31.
32. Bailey GS, Williams DE, Hendricks JD. Fish models for environmental carcinogenesis: The rainbow trout. Environ Health Perspect 1996; 104(Suppl 1): 5-21.
33. Kwak H, Lee M, Cho M. Interrelationship of apoptosis, mutation, and cell proliferation in N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-induced medaka carcinogenesis model. Aquatic Toxicol 2000; 50(4): 317-29.
34. Pichler FB, Laurenson S, Williams LC, Dodd A, Copp BR, Love DR. Chemical discovery and global gene expression analysis in zebrafish. Nat Biotechnol 2003; 21(8): 879-83.
35. Berghmans S, Murphey RD, Wienholds E, Neuberg D, Kutok JL, Fletcher CD, et al. tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors. Proc Natl Aead Sci USA 2005; 102(2): 407-12.
36. Papadopoulos K. Targeting the Bcl-2 family in cancer therapy. Semin Oncol 2006; 33(4): 449-56.
37. Levesque AA, Eastman A. p53-based cancer therapies: Is defective p53 the Achilles heel of the tumor? Carcinogenesis 2007; 28(1): 13-20.
38. Papazoglu C, Mills AA. p53: At the crossroad between cancer and ageing. J Pathol 2007; 211(2): 124-33.
39. Gregory RI, Shiekhattar R. MicroRNA biogenesis and cancer. Cancer Res 2005; 65(9): 3509-12.
40. Jovanovic M, Hengartner MO. miRNAs and apoptosis: RNAs to die for. Oncogene 2006; 25(46): 6176-87.
41. Liu B, Tee KW, Anzo M, Zhang B, Zi X, Tao Y, et al. Insulin-like growth factor-binding protein-3 inhibition of prostate cancer growth involves suppression of angiogenesis. Oncogene 2007; 26(12): 1811-9
42. Brinkmann U. CAS, the human homologue of the yeast chromosome-segregation gene CSE1, in proliferation, apoptosis, and cancer. Am J Hum Genet 1998; 62(3): 509-13.
43. Zeller KI, Jegga AG, Aronow BJ, O'Donnell KA, Dang CV. An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets. Genome Biol 2003; 4(10): R69.
44. Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P. The IARC TP53 database: New online mutation analysis and recommendations to users. Hum Mutat 2002; 19(6): 607-14.
45. Langheinrich U, Hennen E, Stott G, Vacun G. Zebrafish as a model organism for the identification and characterization of drugs and genes affecting p53 signaling. Curr Biol 2002; 12(23): 2023-8.
46. Liu TX, Howlett NG, Deng M, Langenau DM, Hsu K, Rhodes J, et al. Knockdown of zebrafish Fancd2 causes developmental abnormalities via p53-dependent apoptosis. Dev Cell 2003; 5(6): 903-14.
47. Rau Embry M, Billiard SM, Di Giulio RT. Lack of p53 induction in fish cells by model chemotherapeutics. Oncogene 2006; 25(14): 2004-10.
48. Langenau DM, Jette C, Berghmans S, Palomero T, Kanki JP, Kutok JL, et al. Suppression of apoptosis by bcl-2 overexpression in lymphoid cells of transgenic zebrafish. Blood 2005; 105(8): 3278-85.
49. Dhomen Marais R. New insight into BRAF mutations in cancer. Curr Opin Genet Dev 2007; 17(1): 31-9.
50. Patton EE, Widlund HR, Kutok JL, Kopani KR, Amatruda JF, Murphey RD, et al. BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma. Curr Biol 2005; 15(3): 249-54.
51. Zhang B, Pan X, Cobb GP, Anderson TA. microRNAs as oncogenes and tumor suppressors. Dev Biol 2007; 302(1): 1-12.
52. Berezikov E, Plasterk RH. Carneli and zebrafish, viruses and cancer: A microRNA update. Hum Mol Genet 2005; 14(Spec No. 2): R183-90.
53. Schier AF, Giraldez AJ. MicroRNA Function and Mechanism: Insights from Zebra Fish. Cold Spring Harb Symp. Quant Biol 2006; 71: 195-203.
54. Praveen K, Leary JH, 3rd, Evans DL, Jaso-Friedmann L. Molecular cloning of cellular apoptosis susceptibility (CAS) gene in Oreochromis niloticus and its proposed role in regulation of non-specific cytotoxic cell (NCC) functions. Fish Shellfish Immunol 2006; 20(4): 647-55.
55. Langenau DM, Feng H, Berghmans S, Kanki JP, Kutok JL, Look AT. Cre/ lox-regulated transgenic zebrafish model with conditional myc-induced T cell acute lymphoblastic leukemia. Proc Natl Acad Sci USA 2005; 102(17): 6068-73.
56. Langenau DM, Traver D, Ferrando AA, Kutok JL, Aster JC, Kanki JP, et al. Myc-induced T cell leukemia in transgenic zebrafish. Science 2003; 299(5608): 887-90.
57. Yuan J, Yankner BA. Apoptosis in the nervous system. Nature 2000; 407(6805): 802-9.
58. Raff MC, Barres BA, Burne JF, Coles HS, Ishizaki Y, Jacobson MD. Programmed cell death and the control of cell survival: Lessons from the nervous system. Science 1993; 262(5134): 695-700.
59. Mattson MP. Neuronal life-and-death signaling, apoptosis, and neurodegenerative disorders. Antioxid Redox Signal 2006; 8(11-12): 1997-2006.
60. Persaud-Sawin DA, Boustany RM. Cell death pathways in juvenile Batten disesse. Apoptosis 2005; 10(5): 973-85.
61. Tropepe V, Sive HL. Can zebrafish be used as a model to study the neurodevelopmental causes of autism? Genes Brain Behav 2003; 2(5): 268-81.
62. Furutani-Seiki M, Jiang YJ, Brand M, Heisenberg CP, Houart C, Beuchle D, et al. Neural degeneration mutants in the zebrafish, Danio rerio. Development 1996; 123: 229-39.
63. Key B, Devine CA. Zebrafish as an experimental model: Strategies for developmental and molecular neurobiology studies. Methods Cell Sci 2003; 25(1-2): 1-6.
64. Tomasiewicz HG, Flaherty DB, Soria JP, Wood JG. Transgenic zebrafish model of neurodegeneration. J Neurosci Res 2002; 70(6): 734-45.
65. Suram A, Venugopal C, Prakasam A, Sambamurti K. Genotoxicity in Alzheimer's disease: Role of amyloid. Curr Alzheimer Res 2006; 3(4): 365-75.
66. Ohyagi Y, Asahara H, Chui DH, Tsuruta Y, Sakae N, Miyoshi K, et al. Intracellular Abeta42 activates p53 promoter: A pathway to neurodegeneration in Alzheimer's disease. FASEB J 2005; 19(2): 255-7
67. Zhang Y, McLaughlin R, Goodyer C, LeBlanc A. Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons. J Cell Biol 2002; 156(3): 519-29.
68. Xia W. Amyloid metabolism and secretases in Alzheimer's disease. Curr Neurol Neurosci Rep 2001; 1(5): 422-7.
69. Maezawa I, Jin LW, Woltjer RL, Maeda N, Martin GM, Montine TJ, et al. Apolipoprotein E isoforms and apolipoprotein AI protect from amyloid precursor protein carboxy terminal fragment-associated cytotoxicity. J Neurochem 2004; 91(6): 1312-21.
70. Zetterberg H, Campbell WA, Yang HW, Xia W. The cytosolic loop of the gamma-secretase component presenilin enhancer 2 protects zebrafish embryos from apoptosis. J Biol Chem 2006; 281(17): 11933-9.
71. Geling A, Steiner H, Willem M, Bally-Cuif L, Haass C. A gamma-secretase inhibitor blocks Notch signaling in vivo and causes a severe neurogenic phenotype in zebrafish. EMBO Rep 2002; 3(7): 688-94.
72. Dunys J, Kawarai T, Sevalle J, Dolcini V, George-Hyslop PS, Da Costa CA, et al. p53-Dependent Aph-1 and Pen-2 anti-apoptotic phenotype requires the integrity of the gamma-secretase complex but is independent of its activity. J Biol Chem 2007; 282(14): 10516-25.
73. Francis R. McGrath G, Zhang J, Ruddy DA, Sym M, Apfeld J, et al. aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation. Dev Cell 2002; 3(1): 85-97.
74. Campbell WA, Yang H, Zetterberg H, Baulac S, Sears JA, Liu T, et al. Zebrafish lacking Alzheimer presenilin enhancer 2 (Pen-2) demonstrate excessive p53-dependent apoptosis and neuronal loss. J Neurochem 2006; 96(5): 1423-40.
75. Gouras GK, Tsai J, Naslund J, Vincent B, Edgar M, Checler F, et al. Intraneuronal Abeta42-accumulation in human brain. Am J Pathol 2000; 156(1): 15-20.
76. LaFerla FM, Hall CK, Ngo L, Jay G. Extracellular deposition of beta-amyloid upon p53-dependent neuronal cell death in transgenic mice. J Clin Invest 1996; 98(7): 1626-32.
77. Kadowaki H, Nishitoh H, Urano F, Sadamitsu C, Matsuzawa A, Takeda K, et al. Amyloid beta induces neuronal cell death through ROS-mediated ASK1 activation. Cell Death Differ 2005; 12(1): 19-24.
78. Cheung ZH, Ip NY. Cdk5: Mediator of neuronal death and survival. Neurosci Lett 2004; 361(1-3): 47-51.
79. Lin L, Ye Y, Zakeri Z. p53, Apaf-1, caspase-3, and -9 are dispensable for Cdk5 activation during cell death. Cell Death Differ 2006; 13(1): 141-50.
80. Kanungo J, Li BS, Goswami M, Zheng YL, Ramchandran R, Pant HC. Cloning and characterization of zebrafish (Danio rerio) cyclin-dependent kinase 5. Neurosci Lett 2007; 412(3): 233-8.
81. Zheng YL, Li BS, Kanungo J, Kesavapany S, Amin N, Grant P, et al. Cdk5 Modulation of mitogen-activated protein kinase signaling regulates neuronal survival. Mol Biol Cell 2007; 18(2): 404-13.
82. Li BS, Zhang L, Takahashi S, Ma W, Jaffe H, Kulkarni AB, et al. Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3. EMBO J 2002; 21(3): 324-33
83. Camins A, Verdaguer E, Folch J, Canudas AM, Pallas M. The role of CDK5/ P25 formation/inhibition in neurodegeneration. Drug News Perspect 2006; 19(8): 453-60.
84. Kanungo J, Li BS, Zheng Y, Pant HC. Cyclin-dependent kinase 5 influences Rohon-Beard neuron survival in zebrafish. J Neurochem 2006; 99(1): 251-9.
85. Cooper M, Russell C, Mitchison HM. Progress towards understanding disease mechanisms in small vertebrate models of neuronal ceroid lipofuscinosis. Biochim Biophys Acta 2006; 1762(10): 873-89.
86. Schiffer NW, Broadley SA, Hirschberger T, Tavan P, Kretzschmar HA, Giese A, et al. Identification of anti-prion compounds as efficient inhibitors of polyglutamine protein aggregation in a zebrafish model. J Biol Chem 2007; 282(12): 9195-203.
87. Broussard GW, Ennis DG. Mycobacterium marinum produces long-term chronic infections in medaka: A new animal model for studying human tuberculosis. Comp Biochem Physiol C Toxicol Pharmacol 2007; 145(1): 45-54.
88. van der Sar AM, Appelmelk BJ, Vandenbroucke-Grauls CM, Bitter W. A star with stripes: Zebrafish as an infection model. Trends Microbiol 2004; 12(10): 451-7.
89. Hasnainc SE, Begum R, Ramaiah KV, Sahoev S, Shajil EM, Taneja TK, et al. Host-pathogen interactions during apoptosis. J Biosci 2003; 28(3): 349-58.
90. DeLeo FR. Modulation of phagocyte apoptosis by bacterial pathogens. Apoptosis 2004; 9(4): 399-413.
91. Weinrauch Y, Zychlinsky A, The induction of apoptosis by bacterial pathogens. Annu Rev Microbiol 1999; 53: 155-87.
92. Byrne GI, Ojcius DM. Chlamydia and apoptosis: Life and death decisions of an intracellular pathogen. Nat Rev Microbiol 2004; 2(10): 802-8.
93. Gao LY, Kwaik YA. The modulation of host cell apoptosis by intracellular bacterial pathogens. Trends Microbiol 2000; 8(7): 306-13.
94. Hacker G, Fischer SF. Bacterial anti-apoptotic activities. FEMS Microbiol Lett 2002; 211(1): 1-6.
95. Fairbairn IP. Macrophage apoptosis in host immunity to mycobacterial infections. Biochem Soc Trans 2004; 32(Pt3): 496-8.
96. Koul A, Herget T, Klebl B, Ullrich A. Interplay between mycobacteria and host signalling pathways. Nat Rev Microbiol 2004; 2(3): 189-202.
97. Carrero JA, Unanue ER. Lymphocyte apoptosis as an immune subversion strategy of microbial pathogens. Trends Immunol 2006; 27(11): 497-503
98. Gao, L, Abu Kwaik Y. Hijacking of apoptotic pathwaysby bacterial pathogens. Microbes Infect 2000; 2(14): 1705-19.
99. Grassme H, Jendrossek V, Gulbins E. Molecular mechanisms of bacteria induced apoptosis. Apoptosis 2001; 6(6): 441-5.
100. Knodler LA, Finlay BB. Salmonella and apoptosis: To live or let die? Microbes Infect 2001; 3(14-15): 1321-6.
101. Monaek DM, Hersh D, Ghori N, Bouley D, Zychlinsky A, Falkow S. Salmonella exploits caspase-1 to colonize Peyer's patches in a murine typhoid model. J Exp Med 2000; 192(2): 249-58.
102. Voyich JM, Musser JM, DeLeo FR. Streptococcus pyogenes and human neutrophils: A paradigm for evasion of innate host defense by bacterial pathogens. Microbes Infect 2004; 6(12): 1117-13.
103. Garcia-Suarez Mdel M, Florez N, Astudillo A, Vazquez F, Villa-verde R, Fabrizio K, et al. The role bf pneumolysin in mediating lung damage in a lethal pneumococcal pneumonia murine model. Respir Res 2007; 8: 3.
104. Tsai PJ, Lin YS, Kuo CF, Lei HY, Wu JJ. Group A Streptococcus induces apoptosis in human epithelial cells. Infect Immun 1999; 67(9): 4334-9.
105. Bannerman DD, Goldblum SF. Mechanisms of bacterial lipopoly-saccharide-induced endothelial apoptosis. Am J Physiol Lung Cell Mol Physiol 2003; 284(6): L899-914.
106. Hotchkiss RS, Tinsley KW, Swanson PE, Karl IE. Endothelial cell apoptosis in sepsis. Crit Care Med 2002; 30(5 Suppl): S225-8.
107. Kerr JF, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26(4): 239-57.
108. Narayanan SK, Nagaraja TG, Chengappa MM, Stewart GC. Leukotoxins of gram-negative bacteria. Vet Microbiol 2002; 84(4): 337-56.
109. Torrado E, Fraga AG, Castro AG, Stragier P, Meyers WM, Portaels F, et al. Evidence for an intramacrophage growth phase of Mycobacterium ulcerans. Infect Immun 2007; 75(2): 977-87.
110. Braun JS, Novak R, Herzog KE, Bodner SM, Cleveland JL, Tuomanen EI. Neuroprotection by a caspase inhibitor in acute bacterial meningitis. Nat Med 1999; 5(3): 298-302.
111. Clarke P, Debiasi KL, Goody R, Hoyt CC, Richardson-Burns S, Tyler KL. Mechanisms of reovirus-induced cell death and tissue injury: Role of apoptosis and virus-induced perturbation of host-cell signaling and transcription factor activation. Viral Immunol 2005; 18(1): 89-115.
112. Leib SL, Kim YS, Chow LL, Sheldon RA, Tauber MG. Reactive oxygen intermediates contribute to necrotic and apoptotic neuronal injury in an infant rat model of bacterial meningitis due to group B streptococci. J CIin Invest 1996; 98(11): 2632-9.
113. Kaufmann SHE. Immunity to intracellular bacteria. In: Paul WE, Ed. Fundamental Immunology. Fourth ed. Philadelphia, Lippincott Raven Publishers 1999.
114. Nahm MH, Apicella MA, Briles DE. Immunity to extracellular bacteria. In: Paul WE, editor. Fundamental Immunology. Fourth ed. Philadelphia, Lippincott-Raven Publishers 1999; 1373-8.
115. Barber GN. Host defense, viruses and apoptosis. Cell Death Differ 2001; 8(2): 113-26.
116. Gougeon ML. Apoptosises an HIV strategy to escape immune attack. Nat Rev Immunol 2003; 3(5): 392-404.
117. Roulston A, Marcenus RC, Branton PE. Viruses and apoptosis. Annu Rev Microbiol 1999; 33: 577-628.
118. Alcami A, Koszinowski UH. Viral mechanisms of immune evasion. Trends Microbiol 2000; 8(9): 410-8.
119. Hilleman MR. Strategies and mechanisms for host and pathogen survival in acute and persistent viral infections. Proc Natl Acad Sci USA 2004; 101(Suppl 2): 14560-6.
120. O'Brien V. Viruses and apoptosis. J Gen Virol 1998; 79 (Pt 8): 1833-45.
121. Benedict CA, Norris PS, Ware CF. To kill or be killed viral evasion of apoptosis. Nat Immunol 2002; 3(11): 1013-8.
122. Collins M. Potential roles of apoptosis in viral pathogenesis. Am J Respir Crit Care Med 1945; 152(4 Pt 2): 820-4.
123. Everett H, McFadden G. Apoptosis: An innate immune response to virus infection. Trends Microbiol 1992; 7(4): 160-5.
124. Joseph T, Cepica A, Brown L, Ikede BO, Kibenge FS. Mechanism of cell death during infectious salmon-anemia virus-infection is cell type-specific. J Gen Virol 2004; 95(Pt 10): 3027-36.
125. Gao G, Luo H. The ubiquitin-proteasome pathway in viral infections. Can J Physiol Pharmacol 2006; 84(1): 5-14.
126. Cuconati A, White E. Viral homologs of BCL-2: Role of apoptosis in the regulation of virus infection. Genes Dev 2002; 16(19): 2465-78.
127. Thomson BJ. Viruses and apoptosis. Int J Exp Pathol 2001; 82(2): 65-76.
128. Moors MA, Portnoy DA. Identification of bacterial genes that contribute to survival and growth in an intracellular environment. Trends Microbiol 1995; 3(3): 83-5.
129. Rengarajan J, Bloom BR, Rubin EJ. Genomic-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages. Proc Natl Acad Sci USA 2005; 101(23): 8327-32.
130. Dannenberg AM, Jr. Rabbit model of tuberculosis. In: Bloom BR, Ed. Tuberculosis: Pathogenesis, protection and control. Washington DC, American Society for Microbiology 1994; 149-56.
131. Grosset J. Mycobacterium tuberculosis in the extracellular compartment: an underestimated adversary Antimicrob Agents Chemother 2003; 47(3): 833-6.
132. Pamer EG. Immune responses to Listeria monocytogenes. Nat Rev Immunol 2004, 4(10): 812-23.
133. Sly LM, Hingley-Wilson SM, Reiner NE, McMaster, WR. Survival of Mycobacterium tuberculosis in host macrophages involves resistance to apoptosis dependent upon induction of antiapoptotic Bcl-2 family member Mcl-1. J Immunol 2003; 170(1), 430-7.
134. Keane J, Remold HG, Kornfeld H. Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages. J Immunol 2000; 164(4): 2016-20.
135. Lambotin M, Hoffmann I, Laran-Chich MP, Nassif X, Couraud PO, Bourdoulous S. Invasion of endothelial cells by Neisseria meningitidis requires cortactin recruitment by a phosphoinositide-3-kinase/Racl signalling pathway triggered by the lipooligosaccharide. J Cell Sci 2005; 118(Pt 16): 3805-16.
136. Lowy ED. Is Staphylococcus aureus an intracellular pathogen? Trends Microbiol 2000; 8(8): 341-3.
137. Ernst JD. Bacterial inhibition of phagocytosis. Cell Microbiol 2000; 2(5): 379-86.
138. do Vale A, Costa-Ramos C, Silva A, Silva DS, Gartner F, dos Santos NM, et al. Systemic macrophage and neutrophil destruction by secondary necrosis induced by a bacterial exotoxin in a Gram-negative septicaemia. Cell Microbiol 2007; 9(4): 988-1003.
139. do Vale A, Marques F, Silva MT. Apoptosis of sea bass (Dicentrarchus labrax. L.) neutróphils and macrophages induced by experimental infection with Photobacterium damselae subsp. piscicida. Fish Shellfish Immunol 2003; 15(2), 129-44.
140. do Vale A, Silva MT, dos Santos NM, Nascimento DS, Reis-Rodrigues P, Costa-Ramos C, et al. AIP56, a novel plasmid-encoded virulence factor of Photobacterium damselae subsp. piseicida with apoptogenic activity against sea bass macrophages and neutrophils. Mol Microbiol 2005; 58(4): 1025-38.
141. DeLeo FR, Hinnebusch BJ. A plague upon the phagocytes. Nat Med 2005; 11(9): 927-8.
142. Gilmore AP. Anoikis Cell Death Differ 2005; 12(Suppl 2): 1473-7.
143. Marketon, MM, DePaolo RW, DeBord KL, Jabri B, Schneewind O. Plague bacteria target immune cells during infection. Science 2005; 309(5741): 1739-41.
144. Licata JM, Harty RN. Rhabdoviruses ind apoptosis. Int Rev Immunol 2003; 22(5-6): 451-76.
145. Bjorklund HV, Johansson TR, Rinne A. Rhabdovirus-induced apoptosis in a fish cell line is inhibited by a human endogenous acid cysteine proteinase inhibitor. J Virol 1997; 71(7): 5658-62.
146. Jones B, Roberts PJ, Faubion WA, Kominami E, Gores GJ, Cystatin A expression reduces bile salt-induced apoptosis in a rat hepatoma cell line. Am J Physiol 1998; 275(4 Pt 1): G723-30.
147. Nishio C, Yoshida K, Nishiyama K, Hatanaka H, Yamada M. Involvement of cystatin C in oxidative stress-induced apoptosis of cultured rat CNS neurons. Brain Res 2000; 873(2): 252-62.
148. Du C, Zhang Q, Li C, Miao D, Gui J. Induction of apoptosis in acarp leucocyte cell line infected with turbot (Scophthalmus maximus L.) rhabdavirus. Virus Res 2004; 101(2): 119-26.
149. Guo YX, Wei T, Dallmann K, Kwang J. Induction of caspase-dependent apoptosis by betanodaviruses GGNNV and demonstration of protein alpha as an apoptosis inducer. Virology 2003; 308(1): 74-82.
150. Johans R, Ranheim T, Hansen MK, Taksdal T, Totland GK. Pathological changes in juvenile Atlantic halibut Hippoglossus hippoglossus persistently infected with nodavirus. Dis Aquat Organ 2002; 50(3); 161-9.
151. Johansen R, Amundsen M, Dannevig BH, Sommer AI. Acute and persistent experimental nodavirus infection in spotted wolffish Anarhichas minor. Dis Aquat Organ 2003; 57(1-2): 35-41.
152. Chen SP, Yang HL, Her GM, Litt HY, Jeng MF, Wu JL, et al. Betanodavirus induces phosphatidylserine exposure and loss of mitochondrial membrane potential in secondary necrotic cells, both of which are blocked by bongkrekic acid. Virology 2006; 347(2): 379- 1.
153. Kroemer G; Martin SJ. Caspase-independent cell death. Nat Med 2005; 11(7): 725-30.
154. Chen SP, Wu JL, Su YC, Hong JR, Anti-Bcl-2 family members, zfBcl-x(L) and zfMcl-1a, prevent cytochrome c release from cells undergoing betanodavirus-induced secondary necrotic cell death. Apoptosis 2007; 12(6): 1043-60.
155. Dios S, Poisa-Beiro L, Figueras A, Novoa B. Suppression subtraction hybridization (SSH) and macroarray techniques reveal differential gene expression profiles in brain of sea bream infected with nodavirus. Mol Immunol 2007; 44(9): 2195-204.
156. Hong JR, Hsu YL, Wu JL. Infectious pancreatic necrosis virus induces apoptosis due to down-regulation of survival factor MCL-1 protein expression in-a fish cell line. Virus Res 1999; 63(1-2): 75-93.
157. Hong JR, Huang LJ, Wu JL. Aquatic birnavirus induces apoptosis through activated caspase-8 and -3 in a zebrafish cell line. J Fish Dis 2005; 28(3): 133-40.
158. Hong JR, Wu JL. Induction of apoptotic death in cells via Bad gene expression by infectious pancreatic necrosis virus infection. Cell Death Differ 2002; 9(2): 113-24.
159. Hong JR, Gong HY, Wu JL. IPNV VP5, a novel anti-apoptosis gene of the Bcl-2 family, regulates Mcl-1 and viral protein expression. Virology 2002; 295(2): 217-29.
160. Santi N, Sandro A, Sindre H, Song H, Hong JR, Thu B, et al. Infectious pancreatic necrosis virus induces apoptosis in vitro and in vivo independent of VP5 expression. Virology 2005; 342(1): 13-25.
161. Santi N, Song H, Vakharia VN, Evensen O. Infectious pancreatic necrosis virus VP5 is dispensable for virulence and persistence. J Virol 2005; 79(14): 9206-16.
162. Eleouet JF, Druesne N, Chilmonczyk S, Monge D, Dorson M, Delmas B. Comparative study of in-situ cell death induced by the viruses of viral haemorrhagic septicaemia (VHS) and infectious, pancreatic necrosis (IPN) in rainbow trout. J Comp Pathol 2001, 124(4): 300-7.
163. Imajoh M, Hirayama T, Oshima S. Frequent occurrence of apoptosis is not associated with pathogenic infectious pancreatic necrosis virus (IPNV) during persistent infection. Fish Shellfish Immunol 2005; 18(2); 163-77.
164. Chen XH, Lin KB, Wang XW. Outbreak of iridovirus disease in maricultured large yellow croaker, Larimichthys crocea (Richardson), in China. J Fish Dis 2003; 26(10):615-9.
165. Essbauer S, Ahne W. The epizootic haematopoietic necrosis virus (Iridoviridae) induces apotosis in vitro. J Vet Med B Infect Dis Vet Public Health 2002; 49(1): 25-30.
166. Imajoh M, Sugiura H, Oshima S. Morphological changes- contribute to apoptotic cell death and are affected by caspase-3 and caspase-6 inhibitors during red sea bream iridovirus permissive replication. Virology 2004; 322(2): 230-3C.
167. Hu GB, Cong RS, Fan TJ, Mei XG. Induction of apoptosis in a flounder gill cell line by lymphoeystis disease virus infection. J Fish Dis 2004; 27(11): 657-62.
168. Hong JR, Lin TL, Hsu YL, Wu JL. Apoptosis precedes necrosis of fish cell line with infectious pancreatic necrosis virus infection. Virology 1998; 250(): 76-84.
169. Haslett C, Granulocyte apoptosis and its role in the resolution and control of lung inflammation. Am J Respir Crit Care Med 1999; 160(5 Pt 2): S5-11.
170. Zlotkin A, Chilmonczyk S, Eyngor M, Hurvitz A, Ghittino C, Eldar A. Trojan horse effect: Phagocyte-mediated. Streptococcus iniae infection of fish. Infect Immun 2003; 71(5): 2318-25.
171. Liu GY, Doran KS, Lawrence T, Turkson N, Puliti M, Tissi L, et al. Sword and shield: Linked group B streptococal beta-hemolysin/cytolysin and carotenoid pigment function to subvert host-phagocyte defense. Proc Natl Acad Sci USA 2004; 101(40): 14491-6.
172. Miyoshi-Akiyama, T, Takamatsu D, Koyanagi M, Zhao J, Imanishi K, Uchiyama T. Cytocidal effect of Streptococcus pyogenes on mouse neutrophils in vivo and the critical role of streptolysin S. J Infect Dis 2005; 192(1): 107-16.
173. Shao JZ, Liu J, Xiang LX. Aeromonas hydrophila induces apoptosis in Carassius auratus lymphocytes in vitro. Aquaculture 2004; 229: 11-23.
174. Janda JM, Abbott SL. Evolving concepts regarding the genus Aeromonas: An expanding Panorama of species, disease presentations, and unanswered questions. Clin Infect Dis 1998; 27(2): 332-44.
175. Lehane L, Rawlin GT. Topically acquired bacterial zoonoses from fish a review. Med J Aust 2000; 173(5): 256-9.
176. Jeney Z, Jeney G. Recent achievements in studies on diseases of common carp (Cyprinus carpio L.). Aquaculture 1995; 129: 397-420.
177. Falcon RM, Carvalho HF, Joazeiro PP, Gatti MS, Yano T. Induction of apoptosis in HT29 human intestinal epithelial cells by the cytotoxic enterotoxin of Aeromonas hydrophila. Biochem Cell Biol 2001; 79(4): 525-31.
178. Galindo CL, Fadl AA, Sha J, Gutierrez C Jr, Popov VL, Boldogh I, et al. Aeromonas hydrophila cytotoxic enterotoxin activates mitogen-activated protein kinases and induces apoptosis in murine macrophages and human intestinal epithelial cells. J Biol Chem 2004; 279(36): 37597-612.
179. Galindo CL, Gutierrez C Jr, Chopra AK. Potential involvement of galectin-3 and SNAP23 in Aeromonas hydrophila cytotoxic enterotoxin-induced host cell apoptosis. Microb Pathog 2006; 40(2): 56-68.
180. do Vale A, Costa-Ramos C, Silva DS, Macedo PM, Fernandes R, Sampaio P, et al. Cytochemical and ultrastructural study of anoikis and secondary necrosis in enterocytes detached in vivo. Apoptosis 2007; 12(6): 1069-83.
181. Reis MI, do Vale A, Pinto C, Nascimento DS, Costa-Ramos C, Silva DS, et al. First molecular cloning and characterisation of caspase-9 gene in fish and its involvement in a gram negative septicaemia. Mol Immunol 2007; 44(7): 1754-64.
182. Reis MI, Nascimento DS, do Vale A, Silva MT, dos Santos NM. Molecular cloning and characterisation of sea bass (Dicentrarchus labrax L.) caspase-3 gene. Mol Immunol 2007; 44(5): 774-83.
183. Magariños B, Toranzo AE, Romalde JL. Phenotypic and pathobiological characteristics of Pasteurella piscicida. Annu Rev Fish Dis 1996; 6: 41-46.
184. Elkamel AA, Hawke JP, Henk W, Thune RL. Photobacterium damsselae subsp. piscicida is capable of replicating in hybrid striped bass macrophages. J Aquat Anim Health 2003; 15: 175-83.
185. Lopez-Doriga MV, Barnes AC, dos Santos NM, Ellis AE. Invasion of fish epithelial cells by Photobacterium damselae subsp. piscicida: Evidence for receptor specificity, and effect of capsule and serum. Microbiology 2000; 146(Pt 1): 21-30.
186. Tung M-C, Tsai S-S, Ho L-F, Huang S-T, Chen S-C. An acute septicemic infection of Pasteurella organism in pond-cultured formosa snake-head fish (Channa maculata Lacepede) in Taiwan. Fish Pathol 1985; 20(2/3): 143-48.
187. Vermes I, Haanen C, Reutelingsperger C. Flow cytometry of apoptotic cell death. J Immunol Methods 2000; 243(1-2): 167-90.
188. Willingham MC. Cytochemical methods for the detection of apoptosis. J Histochem Cytochem 1990; 47(9): 1101-10.
189. Wyllie AH, Kerr JF, Currie AR. Cell death: The significance of apoptosis. Int Rev Cytol 1980; 68: 251-306.
190. Erjefalt J. Transepithelial migration, necrosis and apoptosis as silent and pro-inflammatory fates of airway granulocytes. Curr Drug Targets Inflamm Allergy 2005; 4(4): 425-31.
191. Ren-Y, Savill J. Apoptosis: The importance of being eaten. Cell Death Differ 1998; 5(7): 563-8.
192. Lauber K, Blumenthal SG, Waibel M, Wesselborg S. Clearance of apoptotic cells: Getting rid of the corpses. Mol Cell 2004; 14(3): 277-87.
193. Savill J, Haslett C. Granulocyte clearance by apoptosis in the resolution of inflammation. Semin Cell Biol 1995; 6(6): 385-93.
194. Kroemer G, Petit P, Zamzami N, Vayssiere JL, Mignotte B. The biochemistry of programmed cell death. FASEB J 1995; 9(13): 1277-87
195. Vander Heiden MG, Chandel NS, Williamson EK, Schumacker PT, Thompson CB. Bcl-xL regulatei the membrane potential and volume homeostasis of mitochondria. Cell 1997; 91(5): 627-37.
196. Serhan CN, Savill J. Resolution of inflammation: The beginning programs the end. Nat Immunol 2005; 6(12): 1191-7.
197. Ono K, Kim SO, Han J. Susceptibility of lysosomes to rupture is a determinant for plasma membrane disruption in tumor necrosis factor alpha-induced cell death. Mol Cell Biol 2003; 23(2): 665-76.
198. Schwab BL, Guerini D, Didszun C, Bano D, Ferrando-May E, Fava E, et al. Cleavage of plasma membrane calcium pumps by caspases: A link between apoptosis and necrosis. Cell Death Differ 2002; 9(8): 818-31
199. Gujral JS, Farhood A, Jaeschke H. Oncotic necrosis and caspase-dependent
200. Hentze H, Schwoebel F, Lund S, Kee M, Ertel W, Wendel A, et al. In vivo and in vitro evidence for extracellular caspase activity released from apoptotic cells. Biochem Biophys Res Commun 2001; 283(5): 1111-7.
201. Kawabata K, Hagio T, Matsuoka S. The role of neutrophil elastase in acute lung injury. Eur J Pharmacol 2002; 451(1): 1-10.
202. Inoue Y, Tanaka H, Ogura H, Ukai I, Fujita K, Hosotsubo H, et al. A neutrophil elastase inhibitor, sivelestat, improves leukocyte deformability in patients with acute lung injury. J Trauma 2006; 60(5): 936-43; discussion 43.
203. Jochum M, Gippner-Steppert C, Machleidt W, Fritz H. The role of phagocyte proteinases and proteinase inhibitors in multiple organ failure. Am J Respir Crit Care Med 1994; 150(6 Pt 2): S123-30.
204. Sebbane F, Gardner D, Long D, Gowen BB, Hinnebusch BJ. Kinetics of disease progression and host response in a rat model of bubonic plague. Am J Pathol 2005; 166(5): 1427-39.
205. Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994; 124(4): 619-26.
206. Meredith JE Jr, Fazeli B, Schwartz MA. The extracellular matrix as a cell survival factor. Mol Biol Cell 1993; 4(9): 953-61.
207. Frisch SM, Screaton RA. Anoikis mechanisms. Curr Opin Cell. Biol 2001; 13(5): 555-62.
208. Reddig PJ, Juliano RL. Clinging to life: Cell to matrix adhesion and cell survival. Cancer Metastasis Rev 2005; 24(3): 425-39.
209. Ringo E, Mikkelsen H, Kaino T, Olsen RE, Mayhew TM, Myklebust R. Endocytosis of indigenous bacteria and cell damage caused by Vibrio anguillarum in the forgut and hindgut of spotted wolffish ( Anarhichas minor Olafsen) fry: An electron microscopical study. Aquaculture Res 2006; 37: 647-51.
210. Laugheinrich U. Zebrafish: A new model on the pharmaceutical catwalk. Bioessays 2003; 25(9): 904-12.
211. Parng C, Roy NM, Ton C, Lin Y, McGrath P. Neurotoxicity assessment using zebrafish. J Pharmacol Toxicol Methods 2007; 55(1): 103-12.
212. Stern HM, Zon LI. Cancer genetics and drug discovery in the zebrafish. Nat Rev Cancer 2003; 3(7): 533-9.
213. Zon LI, Peterson RT. In vivo drug discovery in the zebrafish. Nat Rev Drug Discov 2005; 4(1): 35-44.
214. Parng C. In vivo zebrafish assays for toxicity testing. Curr Opin Drug Discov Devel 2005; 8(1): 100-6.
215. Parng C, Ton C, Lin YX, Roy NM, McGrath P. A zebrafish assay for identifying neuroprotectants in vivo. Neurotoxicol Teratol 2006; 28(4): 509-16.
216. Okun I, Malarchuk S, Dubrovskaya E, Khvat A, Tkachenko S, Kysil V, et al. Screening for caspase-3 inhibitors: A new class of potent small-molecule inhibitors of caspase-3. J Biomol Screen 2006; 11(3): 277-85.
217. Gogal RM Jr, Smith BJ, Kalnitsky J, Holladay SD. Analysis of apoptosis of lymphoid cells in fish exposed to immunotoxic compounds. Cytometry 2000; 39(4): 310-8.
218. Mountz JD, Wu 1, Chang J, Zhou T. Autoimmune disease. A problem of defective apoptosis. Arthritis Rheum 1994; 37(10): 1415-20.
219. Deniaud A, Hoebeke J, Briand JP, Muller S, Jacotot E, Brenner C. Peptido-targeting of the mitochondrial transition pore complex for therapeutic apoptosis induction. Curr Pharm Des 2006; 12(34): 4501-11
220. Molteni A, Wolfe LF, Ward WF, Ts'ao CH, Molteni LB, Veno P, et al. Effect of an angiotensin II receptor blocker and two angiotensin converting enzyme inhibitors on transforming growth factor-beta (TGF-beta) and alpha-aotomyosin (alpha SMA), important mediators of radiation-induced pneumopathy and lung fibrosis. Curr Pharm Des 2007; 13(13): 1307-16.
221. Moulder JE, Fish BL, Cohen EP. Treatment of radiation nephropathy with ACE inhibitors and All type-1 and type-2 receptor antogonists. Curr Pharm Des 2007; 13(13): 1317-25.